Physico-Chemical Characterization and In Vitro Biological Evaluation of Pure SiHA for Bone Tissue Engineering Application


Article Preview

Studies about silicon-substituted hydroxyapatites exhibit several shortcomings that leave unanswered questions regarding the properties and subsequent biological outcomes generated by this biomaterial. Firstly, samples characterization is often incomplete, meaning that phase purity on the pellet surface is not assured. In fact, ceramic materials used in literature that are claimed to be pure are actually polluted through second phase as superficial polymerized silicate. In this study, we have successfully synthesized a phase pure silicon hydroxyapatite powder Ca10(PO4)5.5(SiO4)0.5(OH)1.5 (Si0.5HA) compressed this powder into pellets, sintered them, and evaluated the biological response of osteoblast cells (C3H10 line) seeded on the pellet surface. Besides, the solubility in aqueous media of HA and Si0.5HA pellets were determined through static experiments. These tests attempt to provide a comprehensive picture of the cellular response to the SiHA material, in order to determine the mechanism by which Si evokes the improved in vitro biological outcomes described in the literature. Results revealed first an equivalent solubility of Si0.5HA and HA pellets, and second that cells do not react favourably to the pure SiHA surface.



Key Engineering Materials (Volumes 529-530)

Main Theme:

Edited by:

Kunio Ishikawa and Yukihide Iwamoto




D. Marchat et al., "Physico-Chemical Characterization and In Vitro Biological Evaluation of Pure SiHA for Bone Tissue Engineering Application", Key Engineering Materials, Vols. 529-530, pp. 351-356, 2013

Online since:

November 2012




[1] Best SM, Zou S, Brooks RA, Huang J, Rushton N, Bonfield W. The osteogenic behaviour of silicon substituted hydroxyapatite. Key Engineering Materials 2008; 361-363: 985-8.


[2] Hing KA, Wilson LF, Buckland T. Comparative performance of three ceramic bone graft substitutes. The Spine Journal 2007; 7: 475-90.


[3] Pietak AM, Reid JW, Stott MJ, Sayer M. Silicon substitution in the calcium phosphate bioceramics. Biomaterials 2007; 28: 4023-32.


[4] Porter AE, Buckland T, Hing KA, Best SM, Bonfield W. The structure of the bond between bone and porous Si-HA bioceramic implants. Journal of Biomedical Materials Research 2006; 78A: 25-33.


[5] Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials 2003; 24: 4609-20.


[6] Boanini E, Gazzano M, Bigi A. Ionic substitutions in calcium phosphates synthesized at low temperature. Acta Biomaterialia 2010; 6: 1882-94.


[7] Bohner M. Silicon-substituted calcium phosphates – A critical view. Biomaterials 2009; 30: 6403-6.


[8] Zymelka M, Marchat D, Szenknect S, Dacheux N, Bernache-Assollant D, Chevalier J. Silicon-substituted hydroxyapatite particles precipitation and dissolution. Acta Biomaterialia 2012; (Submitted).


[9] Marchat D, Zymelka M, Gremillard L, Coelho C, Joly-Pottuz L, Babonneau F, et al. Accurate characterization of silicon-substituted hydroxyapatites powders synthesized by a new precipitation route. Acta Biomaterialia 2012; (Submitted).


[10] Marchat D, Bernache-Assollant D, Champion E. Cadmium fixation by synthetic hydroxyapatite particles in aqueous solution - Kinetic study. Journal of Hazardous Materials 2011; to be submitted.


[11] Rey C, Collins B, Goehl T, Dickson IR, Glimcher MJ. The carbonate environment in bone mineral: a resolution enhanced Fourier transform infrared spectroscopy study. Calcified Tissue International 1989; 45: 157-64.


[12] Dacheux N, Du Fou de Kernadiel E, Clavier N, Podor R, Aupias J, Szenknect S. Kinetics of dissolution of thorium and uranium doped britholite ceramics. Journal of Nuclear Materials 2010; 404: 33-43.


[13] Jillavenkatesa A, Condrate RA. The infrared and Raman spectra of b and a tricalcium phosphate (Ca3(PO4)2). Spectroscopy letters 1998; 31: 1619-34.